Oxygen therapy provider Vivisol, part of the Italian gas company SOL group, has won three regional NHS tenders through its UK subsidiary Dolby Vivisol.
Bridgepoint is reportedly pitching to banks for an IPO of its international dialysis provider Diaverum after a failed private auction, HBI is told. We name likely second-round participants, reasons why they might have pulled out, and whether Diaverum can better the valuations of listed peers.
French private equity firm Ardian has acquired a majority stake in Santé Cie, the parent company of medicalised homecare specialists Elivie and Asdia. We discuss Santé Cie's plans and the wider market with an expert in the respiratory sector from advisors Candesic.
Pan-European radiotherapy group MedEuropa has entered the French market by acquiring a radiotherapy clinic on the site of an Elsan hospital. HBI speaks to CEO Ralph Hefti.
Shares at SIX listed SHL Telemedicine have jumped 9% at the confirmation that it is in talks for a possible takeover, with publicly listed Danal Group among the interested parties. HBI has increased its likelihood of a sale in the next 12 months to 85% in the HBI Pipeline.
Dutch and Nordic ambulatory clinic operator Bergman Clinics is likely to be put up for sale in the first quarter of this year, independent sources tell HBI.
Ameos, Germany's largest for-profit psychiatric provider by revenue, is bidding for a non-profit university hospital in Saxony-Arnhalt, northwestern Germany, alongside SRH Kliniken, a top-ten for-profit hospital group. We hear publicly-owned hospitals are in trouble and this could open up opportunities for the private sector across the country.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
